EP4427794A1 — Microneedle assembly
Assigned to Daewoong Therapeutics Inc · Expires 2024-09-11 · 2y expired
What this patent protects
An example embodiment of the present disclosure provides a microneedle assembly including: a mold having one or more concave portions formed in an upper surface thereof and microneedles molded by being injected into the one or more concave portions; and an applicator detachably c…
USPTO Abstract
An example embodiment of the present disclosure provides a microneedle assembly including: a mold having one or more concave portions formed in an upper surface thereof and microneedles molded by being injected into the one or more concave portions; and an applicator detachably coupled to the upper surface of the mold, in which the applicator is formed in a plate shape, and has a first surface which protects the microneedles so that the microneedles are not to be exposed during packaging and a second surface on which an adhesion portion is formed to be attached to the microneedles during use.
Drugs covered by this patent
- Jublia (EFINACONAZOLE) · Bausch Health
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.